Prime time for chronic kidney disease

Chronic kidney disease (CKD) represents a public health burden worldwide and is associated with significant morbidity and mortality. Most patients with CKD are managed by primary care practitioners and this educational series hope to improve knowledge and delivery of care to this high-risk patient p...

Descripción completa

Detalles Bibliográficos
Autores principales: Weisman, David S., Thavarajah, Sumeska, Jaar, Bernard G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559593/
https://www.ncbi.nlm.nih.gov/pubmed/37803275
http://dx.doi.org/10.1186/s12882-023-03340-w
_version_ 1785117535879823360
author Weisman, David S.
Thavarajah, Sumeska
Jaar, Bernard G.
author_facet Weisman, David S.
Thavarajah, Sumeska
Jaar, Bernard G.
author_sort Weisman, David S.
collection PubMed
description Chronic kidney disease (CKD) represents a public health burden worldwide and is associated with significant morbidity and mortality. Most patients with CKD are managed by primary care practitioners and this educational series hope to improve knowledge and delivery of care to this high-risk patient population with CKD.
format Online
Article
Text
id pubmed-10559593
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105595932023-10-08 Prime time for chronic kidney disease Weisman, David S. Thavarajah, Sumeska Jaar, Bernard G. BMC Nephrol Editorial Chronic kidney disease (CKD) represents a public health burden worldwide and is associated with significant morbidity and mortality. Most patients with CKD are managed by primary care practitioners and this educational series hope to improve knowledge and delivery of care to this high-risk patient population with CKD. BioMed Central 2023-10-06 /pmc/articles/PMC10559593/ /pubmed/37803275 http://dx.doi.org/10.1186/s12882-023-03340-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Editorial
Weisman, David S.
Thavarajah, Sumeska
Jaar, Bernard G.
Prime time for chronic kidney disease
title Prime time for chronic kidney disease
title_full Prime time for chronic kidney disease
title_fullStr Prime time for chronic kidney disease
title_full_unstemmed Prime time for chronic kidney disease
title_short Prime time for chronic kidney disease
title_sort prime time for chronic kidney disease
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559593/
https://www.ncbi.nlm.nih.gov/pubmed/37803275
http://dx.doi.org/10.1186/s12882-023-03340-w
work_keys_str_mv AT weismandavids primetimeforchronickidneydisease
AT thavarajahsumeska primetimeforchronickidneydisease
AT jaarbernardg primetimeforchronickidneydisease

Ejemplares similares